Wong WL, Su X, Li X, Cheung CMG, Klein R, Cheng C-Y, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2:e106–16.

Article  PubMed  Google Scholar 

Pershing S, Talwar N, Armenti ST, Grubbs J Jr, Rosenthal JM, Dedania VS, et al. Use of bevacizumab and ranibizumab for wet age-related macular degeneration: influence of CATT results and introduction of aflibercept. Am J Ophthalmol. 2019;207:385–94.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Holtz JK, Thinggaard BS, Grauslund J, Subhi Y. Association between oral metformin use and the risk of age‐related macular degeneration: a systematic review with meta‐analysis. Acta Ophthalmol. 2023;101:595–605.

Article  CAS  PubMed  Google Scholar 

Grimes KR, Aloney A, Skondra D, Chhablani J. Effects of systemic drugs on the development and progression of age-related macular degeneration. Surv Ophthalmol. 2023;68:332–46.

Article  PubMed  Google Scholar 

Glassman AR, Wells JA III, Josic K, Maguire MG, Antoszyk AN, Baker C, et al. Five-year outcomes after initial aflibercept, bevacizumab, or ranibizumab treatment for diabetic macular edema (Protocol T Extension Study). Ophthalmology. 2020;127:1201–10.

Article  PubMed  Google Scholar 

Lin L-W, Wang S-W, Huang W-C, Huynh TK, Lai C-Y, Ko C-Y, et al. Melatonin inhibits VEGF-induced endothelial progenitor cell angiogenesis in neovascular age-related macular degeneration. Cells. 2023;12:799.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sobrin L, Susarla G, Stanwyck L, Rouhana JM, Li A, Pollack S, et al. Gene set enrichment analsyes identify pathways involved in genetic risk for diabetic retinopathy. Am J Ophthalmol. 2022;233:111–23.

Article  CAS  PubMed  Google Scholar 

Léveillard T, Philp NJ, Sennlaub F. Is retinal metabolic dysfunction at the center of the pathogenesis of age-related macular degeneration? Int J Mol Sci. 2019;20:762.

Article  PubMed  PubMed Central  Google Scholar 

Järgen P, Dietrich A, Herling AW, Hammes H-P, Wohlfart P. The role of insulin resistance in experimental diabetic retinopathy—genetic and molecular aspects. PloS ONE. 2017;12:e0178658.

Article  PubMed  PubMed Central  Google Scholar 

Sarkar A, Sodha SJ, Junnuthula V, Kolimi P, Dyawanapelly S. Novel and investigational therapies for wet and dry age-related macular degeneration. Drug Discov Today. 2022;27:2322–32.

Article  CAS  PubMed  Google Scholar 

Chua SY, Welsh P, Sun Z, Balaskas K, Warwick A, Steel D, et al. Associations between HbA1c across the normal range, diagnosed, and undiagnosed diabetes and retinal layer thickness in UK Biobank cohort. Transl Vis Sci Technol. 2023;12:25.

Article  PubMed  PubMed Central  Google Scholar 

Ramos H, Bogdanov P, Huerta J, Deàs-Just A, Hernández C, Simó R. Antioxidant effects of DPP-4 inhibitors in early stages of experimental diabetic retinopathy. Antioxidants. 2022;11:1418.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Maeda S, Yamagishi S-I, Matsui T, Nakashima S, Ojima A, Maeda S, et al. Beneficial effects of vildagliptin on retinal injury in obese type 2 diabetic rats. Ophthalmic Res. 2013;50:221–6.

Article  CAS  PubMed  Google Scholar 

Lin W-J, Ma X-F, Hao M, Zhou H-R, Yu X-Y, Shao N, et al. Liraglutide attenuates the migration of retinal pericytes induced by advanced glycation end products. Peptides. 2018;105:7–13.

Article  CAS  PubMed  Google Scholar 

Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2022;79:e263–421.

Article  PubMed  Google Scholar